Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001785163 | SCV002020956 | likely pathogenic | Glucocorticoid deficiency with achalasia | 2021-04-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003442904 | SCV004168296 | pathogenic | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 28371804, 29874194, 31937715) |
Labcorp Genetics |
RCV003442904 | SCV004294190 | pathogenic | not provided | 2023-12-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser255Valfs*36) in the AAAS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AAAS are known to be pathogenic (PMID: 11159947). This variant is present in population databases (rs746057093, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with Achalasia-addisonianism-alacrimia syndrome (PMID: 29874194, 31937715). ClinVar contains an entry for this variant (Variation ID: 1323789). For these reasons, this variant has been classified as Pathogenic. |